Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation

被引:11
|
作者
Perez, Ariadna [1 ]
Montoro, Juan [2 ]
Hernani, Rafael [1 ]
Lorenzo, Ignacio [2 ]
Carlos Hernandez-Boluda, Juan [1 ,3 ]
Gimenez, Estela [4 ]
Dolores Gomez, Maria [5 ]
Balaguer-Rosello, Aitana [2 ]
Gonzalez-Barbera, Eva [5 ]
Guerreiro, Manuel [2 ]
Aguilar, Cristobal [2 ]
Navarro, David [3 ,4 ]
Solano, Carlos [1 ,3 ]
Sanz, Jaime [2 ,3 ,6 ]
Luis Pinana, Jose [2 ,6 ]
机构
[1] Fdn INCLIVA, Hosp Clin Univ, Dept Hematol, Valencia, Spain
[2] Hosp Univ & Politecn la Fe, Dept Hematol, Valencia, Spain
[3] Univ Valencia, Sch Med, Dept Med, Valencia, Spain
[4] Hosp Clin Univ, Microbiol Serv, Valencia, Spain
[5] Univ Valencia, Sch Med, Dept Microbiol, Valencia, Spain
[6] Inst Carlos III, CIBERONC, Madrid, Spain
关键词
allogeneic stem cell; community acquired respiratory virus; immunodeficiency scoring index; rhinovirus; trasplantation; HUMAN RHINOVIRUS INFECTIONS; INFLUENZA INFECTIONS; PARAINFLUENZA VIRUS; SYNCYTIAL VIRUS; RECIPIENTS; OUTCOMES; ADULTS; TRACT;
D O I
10.1111/tid.13301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Enterovirus/rhinoviruses (EvRh) are the most common cause of respiratory virus infections in recipients of allogeneic stem cell transplantation (allo-HSCT). Objective We sought to analyze the value of the immunodeficiency scoring index (ISI) in predicting lower respiratory tract disease (LRTD) progression and mortality in a prospective cohort of consecutive adult (>16 years) allo-HSCT recipients with EvRh infection from December 1 2013 to December 1 2019 at two Spanish transplant centers. Results We included 234 allo-HSCT recipients with 383 EvRh episodes. Out of 383 EvRh episodes, 98 (25%) had LRTD. Multivariate logistic regression analysis identified three independent factors associated with LRTD progression: Ig G < 400 mg/dL, community-acquired respiratory virus (CARV) co-infection and high-risk ISI. Inclusion of Ig G levels and CARV co-infection in the ISI improved its performance by significantly increasing the area under the receiver operator characteristic curve (AUROC) from 0.643 to 0.734 (P = .03). Likewise, the two conditions identified by multivariate analyses as associated with higher probability of mortality were high-risk ISI and EvRh infection within 6 months after transplant. Conclusions Our findings confirm the value of high-risk ISI in predicting both probability of EvRh LRTD and 3-month overall mortality. We also demonstrate that the original ISI could be adapted to other CARV types by including additional variables to improve its performance.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
    Stein, Anthony S.
    Kantarjian, Hagop
    Goekbuget, Nicola
    Bargou, Ralf
    Litzow, Mark R.
    Rambaldi, Alessandro
    Ribera, Josep-Maria
    Zhang, Alicia
    Zimmerman, Zachary
    Zugmaier, Gerhard
    Topp, Max S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (08) : 1498 - 1504
  • [32] Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation
    Bhatt, Vijaya Raj
    Balasetti, Vamshi
    Jasem, Jagar A.
    Giri, Smith
    Armitage, James O.
    Loberiza, Fausto R., Jr.
    Bociek, R. Gregory
    Bierman, Philip J.
    Maness, Lori J.
    Vose, Julie M.
    Fayad, Pierre
    Akhtari, Mojtaba
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (10) : 606 - 611
  • [33] Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation
    Mendorf, Alexander
    Klyuchnikov, Evgeny
    Langebrake, Claudia
    Rohde, Holger
    Ayuk, Francis
    Regier, Marc
    Christopeit, Maximilian
    Zabelina, Tatjana
    Bacher, Adelbert
    Stuebig, Thomas
    Wolschke, Christine
    Bacher, Ulrike
    Kroeger, Nicolaus
    ACTA HAEMATOLOGICA, 2015, 134 (03) : 146 - 154
  • [34] Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management
    Griffith, Michelle L.
    Savani, Bipin N.
    Boord, Jeffrey B.
    BLOOD, 2010, 116 (08) : 1197 - 1204
  • [35] Noninfectious Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation
    Balaguer-Rosello, Aitana
    Bataller, Luis
    Luis Pinana, Jose
    Montoro, Juan
    Lorenzo, Ignacio
    Villalba, Ana
    Freiria, Carmen
    Santiago, Marta
    Sevilla, Teresa
    Muelas, Nuria
    Guerreiro, Manuel
    Carretero, Carlos
    Gomez, Ines
    Solves, Pilar
    Angel Sanz, Miguel
    Sanz, Guillermo
    Sanz, Jaime
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1818 - 1824
  • [36] Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation
    Veeraputhiran, Muthu
    Yang, Lingyao
    Sundaram, Vandana
    Arai, Sally
    Lowsky, Robert
    Miklos, David
    Meyer, Everett
    Muffly, Lori
    Negrin, Robert
    Rezvani, Andrew
    Shizuru, Judith
    Weng, Wen Kai
    Johnston, Laura
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (10) : 1744 - 1748
  • [37] Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
    Asakura, Maiko
    Ikegame, Kazuhiro
    Yoshihara, Satoshi
    Taniguchi, Shuichi
    Mori, Takehiko
    Etoh, Tetsuya
    Takami, Akiyoshi
    Yoshida, Takashi
    Fukuda, Takahiro
    Hatanaka, Kazuo
    Kanamori, Heiwa
    Yujiri, Toshiaki
    Atsuta, Yoshiko
    Sakamaki, Hisashi
    Suzuki, Ritsuro
    Ogawa, Hiroyasu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (02) : 351 - 359
  • [38] Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome
    Willems, Lise
    Porcher, Raphael
    Lafaurie, Matthieu
    Casin, Isabelle
    Robin, Marie
    Xhaard, Alienor
    Andreoli, Anna Lisa
    Rodriguez-Otero, Paula
    Dhedin, Nathalie
    Socie, Gerard
    Ribaud, Patricia
    de Latour, Regis Peffault
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (08) : 1295 - 1301
  • [39] Monitoring of cytomegalovirus infection after allogeneic stem cell transplantation
    Kuljic-Kapulica, Nada
    Stamatovic, Dragana
    Savic, Dejana
    Jovanovic, Dragutin
    Tukic, Ljiljana
    Andjelkovic, Nebojsa
    VOJNOSANITETSKI PREGLED, 2010, 67 (05) : 375 - 378
  • [40] Cigarette Smoking and Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
    Tran, Betty T.
    Halberin, Abigail
    Chien, Jason W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (07) : 1004 - 1011